Unknown

Dataset Information

0

What We Learned about COVID-19 So Far? Notes from Underground.


ABSTRACT: The novel coronavirus pandemic poses a major global threat to public health. Our knowledge concerning every aspect of COVID-19 is evolving rapidly, given the increasing data from all over the world. In this narrative review, the Turkish Thoracic Society Early Career Taskforce members aimed to provide a summary on recent literature regarding epidemiology, clinical findings, diagnosis, treatment, prevention, and control of COVID-19. Studies revealed that the genetic sequence of the novel coronavirus showed significant identity to SARS-CoV and MERS-CoV. Angiotensin-converting enzyme 2 receptor is an important target of the SARS-CoV-2 while entering an organism. Smokers were more likely to develop the disease and have a higher risk for ICU admission. The mean incubation period was 6.4 days, whereas asymptomatic transmission was reported up to 25 days after infection. Fever and cough were the most common symptoms, and cardiovascular diseases and hypertension were reported to be the most common comorbidities among patients. Clinical manifestations range from asymptomatic and mild disease to severe acute respiratory distress syndrome. Several patients showed typical symptoms and radiological changes with negative RT-PCR but positive IgG and IgM antibodies. Although radiological findings may vary, bilateral, peripherally distributed, ground-glass opacities were typical of COVID-19. Poor prognosis was associated with older age, higher Sequential Organ Failure Assessment score, and high D-dimer level. Chloroquine was found to be effective in reducing viral replication in vitro. Likewise, protease inhibitors, including lopinavir/ritonavir, favipiravir, and nucleoside analogue remdesivir were proposed to be the potential drug candidates in COVID-19 management. Despite these efforts, we still have much to learn regarding the transmission, treatment, and prevention of COVID-19.

SUBMITTER: Aky?l FT 

PROVIDER: S-EPMC7311152 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

What We Learned about COVID-19 So Far? Notes from Underground.

Akyıl Fatma Tokgöz FT   Karadoğan Dilek D   Gürkan Canan Gündüz CG   Yüksel Aycan A   Arıkan Hüseyin H   Eyüboğlu Tuğba Şişmanlar TŞ   Emiralioğlu Nagehan N   Gürsoy Tuğba Ramaslı TR   Şerifoğlu İrem İ   Töreyin Zehra Nur ZN   Marim Feride F   Kara Bilge Yılmaz BY   Özakıncı Hilal H   Develi Elif E   Çakmakçı Selin S   Küsbeci Tuba Çiftçi TÇ   Karcıoğlu Oğuz O   Gülhan Pınar Yıldız PY   Erçelik Merve M   Er Berrin B   Ataoğlu Özlem Ö   Polat Demet D   Kaya İlknur İ   Önyılmaz Tuğba Aslı TA   Aydın Asena A   Kızılırmak Deniz D   Er Aslıhan Banu AB   Kılınç Mukaddes M   Günaydın Fatma Esra FE   Gürz Selçuk S   Karaoğlanoğlu Selen S   Çelik Selma S   Esendağlı Dorina D   Toptay Hüseyin H   Sertçelik Ümran Özden ÜÖ   Akgün Metin M  

Turkish thoracic journal 20200501 3


The novel coronavirus pandemic poses a major global threat to public health. Our knowledge concerning every aspect of COVID-19 is evolving rapidly, given the increasing data from all over the world. In this narrative review, the Turkish Thoracic Society Early Career Taskforce members aimed to provide a summary on recent literature regarding epidemiology, clinical findings, diagnosis, treatment, prevention, and control of COVID-19. Studies revealed that the genetic sequence of the novel coronavir  ...[more]

Similar Datasets

| S-EPMC8975445 | biostudies-literature
| S-EPMC7311134 | biostudies-literature
| S-EPMC7997052 | biostudies-literature
| S-EPMC7834261 | biostudies-literature
| S-EPMC7179500 | biostudies-literature
| S-EPMC9321859 | biostudies-literature
| S-BSST563 | biostudies-other
| S-EPMC7273118 | biostudies-literature
| S-EPMC7674982 | biostudies-literature
| S-EPMC3893087 | biostudies-literature